2.725USD+1.30%Mkt Cap: 126.48M USDP/E: —Last update: 2026-05-26
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that e…
Industry Peers
Medical Devices151.38BUSDP/E 24.3
119.84BUSDP/E 36.2
86.12BUSDP/E 24.2
54.95BSEKP/E 101.9
53.92BSEKP/E 22.9
52.13BDKKP/E 22.1
50.54BUSDP/E 47.4
39.31BEURP/E 18.6
Indicators:|
Key Statistics
Company
Market Cap126.48M USD
Enterprise Value60.43M USD
Revenue (TTM)144.98M USD
Gross Profit64.72M USD
Net Income (TTM)-107.15M USD
Revenue/Share3.243 USD
Last Price2.725 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees450
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.94
PEG—
EV/EBITDA-0.95
EV/Revenue0.42
P/S0.86
P/B0.44
EPS (TTM)-2.35
EPS (Forward)-1.36
52W Range
2.3955% of range8.770
52W High8.770 USD
52W Low2.395 USD
Profitability
Gross Margin46.67%
Oper. Margin-59.12%
EBITDA Margin-43.92%
Profit Margin-77.28%
ROE-36.23%
ROA-25.59%
Growth
Revenue Growth20.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-77.24M USD
CapEx (TTM)2.61M USD
FCF Margin-15.16%
FCF Yield-17.38%
Net Debt-63.93M USD
Net Debt/EBITDA1.00
Balance Sheet
Debt/Equity0.13
Current Ratio3.72
Quick Ratio2.54
Book Value/Sh5.995 USD
Cash/Share2.107 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating3.0 (Hold)
Target (Mean)4.333 USD
Target Range4.000 USD – 5.000 USD
# Analysts3
Ownership
Shares Out.47.11M
Float38.49M
Insiders6.24%
Institutions85.44%
Short Interest
Short Ratio4.6d
Short % Float11.00%
Short % Out.9.76%
Shares Short4.60M
Short (prev mo.)4.32M
Technical
SMA 503.446 (-20.9%)
SMA 2005.293 (-48.5%)
Beta1.15
S&P 52W Chg28.31%
Avg Vol (30d)1.33M
Avg Vol (10d)1.69M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—